Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

A team led by Paul Hergenrother at the University of Illinois Urbana-Champaign has discovered a new antibiotic that exclusively targets gram-negative bacteria and avoids wiping out the ecosystem ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

An experimental antibiotic, zosurabalpin, to fight a deadly superbug has entered the final human trials. Currently, no new ...

How can we prevent antibiotics from becoming obsolete? All that said, when it comes to antibiotic resistance, gram-negative bacteria have an edge thanks to their double membranes. The outer ...

Infection control standards need to be followed closely to prevent the development and spread of antibiotic-resistant infections. Gram-negative bacteria have a hard, protective outer shell.

and "thus colistin is typically utilized only as an antibiotic of last resort," the researchers wrote. To tackle the many problems associated with indiscriminately targeting gram-negative bacteria ...

Gram-positive bacteria show blue or purple after Gram-staining in a laboratory test. They have thick cell walls. Gram-negative bacteria show pink or red on staining and have thin walls. They ...